German drug regulator has hailed the European Medicine Agency's decision to suspend the marketing authorisation of more than 700 generic drugs subjected to clinical trials by India's GVK Biosciences. The decision is being seen as the EU's determination to maintain high ethical and medical standards for approval of medicines. The EU drug regulator's announcement is also an endorsement of the Federal Institute for Drugs and Medical Devices' (BfArM) ...
Read More
You have just read an article categorized health
titled German Regulator Hails EMA's Generic Drugs Suspension on GVK Bio Data.
Written by:
editor -
Tuesday, January 27, 2015
There are currently no comments for "German Regulator Hails EMA's Generic Drugs Suspension on GVK Bio Data"
Post a Comment